Drug Discovery Technologies Market and COVID-19 Impact Assessment Report 2021
Dublin, April 08, 2021 (GLOBE NEWSWIRE) -- The "Drug Discovery Technologies" report has been added to ResearchAndMarkets.com's offering.
The drug discovery industry witnessed growth in the past several years owing to progress in biochemical, translational and molecular studies in biomedical research. These technologies are commercially employed in the development of new and efficient drug candidates. The booming healthcare sector and increased government funding have aided notable growth in this market. The delineation of mechanistic details and the underlying mechanisms of drug-target interaction have paved the way for more accurate and effective therapies.
The growing field of drug discovery and development is enabling researchers to focus on discovering essential lead compounds for different forms of cancer and other diseases. Biopharmaceutical companies and various research institutes are conducting research in the field of drug discovery technologies. Globally, research institutes and biopharmaceutical companies are exploring several molecular and biochemical aspects to develop mechanistic approaches for drug discovery. Various technologies, such as high-throughput screening, proteomics and genomics, including quantitative reverse transcription-polymerase chain reaction (qRT-PCR), next-generation sequencing (NGS) and many others, are being widely used for cellular analysis.
A rise in R&D, increasing incidences of various life-threatening diseases, and the increasing global population are all market drivers. The companies in this industry are focusing on enhancing biomedical research and the advancement of superior technologies in order to provide better quality treatments and therapies.
Collaborative efforts of researchers and the pharmaceutical industry are establishing various promising future drug candidates. Drug discoveries find applications in cardiovascular, neurological, cancer and other disease areas. However, the rapid spread of COVID-19 has thrown countless businesses into a frenzy. The healthcare industry, in particular, is facing growing pressure to rapidly-produce tests needed in nearly every region around the world.
The virus has created unprecedented challenges for the healthcare industry. COVID-19 has put the healthcare industry at center stage with the remarkable demand for diagnostic tests, personal protective equipment (PPE), ventilators and other critical medical supplies. Moreover, for the unusual measures underway to rapidly ramp up manufacturing capacity and capabilities, healthcare leaders are also looking outside their normal sector boundaries to explore creative solutions to supplement further capacity, like partnerships with companies outside the sector, open-source equipment design and deployment of medically trained employees to support public-health needs.
The report includes:
An overview of the global market for drug discovery technologies
Estimation of the market size and analyses of global market trends, with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025
Evaluation of market forecast, pipeline analysis of new products, regulatory scenarios and detailed analysis of drivers, challenges, and opportunities affecting the market growth
Market share analysis of drug discovery technologies based on type, application, end-user, and region
Information on reverse transcription-polymerase chain reaction (qRT-PCR), and next-generation sequencing (NGS) and coverage of bioanalytical instruments used for drug discovery
Information on pharmacokinetics and pharmacodynamics, and classification of techniques used in drug discovery
Discussion on bioinformatics as a platform for drug discovery and comparison between proteomics and genomics drug discovery technology
Detailed description of COVID-19 including symptoms and progression, its effect on medical tourism and insurance providers and coverage of government expenditure on COVID-19
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Comprehensive company profiles of major players of the industry, including Thermo Fisher Scientific, General Electric Co., Agilent, Illumina, Merck KGaA and Bio-Rad Laboratories
Key Topics Covered
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Chapter 2 Summary and Highlights
Market Highlights: Drug Discovery Technologies
Chapter 3 Impact of COVID-19 Pandemic
Introduction
Outbreak
Symptoms of COVID-19
Progression of COVID-19
Spread of Disease
Impact on Medical Device Market
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Medical Tourism
Impact of COVID-19 on Pharma Supply Chain
Impact of COVID-19 on the Global Economy
Government Expenditure on COVID-19
Impact on Insurance Providers
Impact of COVID-19 on Drug Discovery Technologies Industry
Clinical Trials on Hold
New Reality for Ongoing Studies
Ensuring Access to Study Drugs
Chapter 4 Market and Technology Background
Some Related Terms
Toxicity
Metabolism
Analytical Chemistry
Pharmacokinetics
Pharmacodynamics
Introduction
Process of Drug Discovery
History of Drug Discovery
Classification of Techniques Used in Drug Discovery
High-throughput Screening
Bioanalytical Instruments for Drug Discovery
Cell-based Assays and Reagents for Drug Discovery
Proteomics Drug Discovery Technologies
Genomics Drug Discovery Technologies
Bioinformatics as Platform for Drug Discovery
Others: Metabolomics-based Technologies, Combinatorial Chemistry, Systems Biology, Nanotechnology
Chapter 5 Market Breakdown by Technology Type
High-Throughput Screening (HTS)
Bioanalytical Instruments for Drug Discovery
Cell-Based Assays and Reagents for Drug Discovery
Proteomics Drug Discovery
Genomics Drug Discovery
Bioinformatics as Platform for Drug Discovery
Others Drug Discovery Technologies
Chapter 6 Market Breakdown by Disease Application
Cancer Diseases
Cardiovascular Diseases
Immunological Diseases
Neurological Diseases
Others
Chapter 7 Market Breakdown by End-user
Biopharmaceutical Companies
Research and Academia
Contract Research Organizations (CROs)
Chapter 8 Market Breakdown, by Region
Global Market for Drug Discovery Technologies, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 9 Industry Structure
High-Throughput Screening
Bioanalytical Instruments
Cell-Based Assays and Reagents
Proteomics
Genomics
Bioinformatics
Other Drug Discovery Technologies
Chapter 10 Patent Review/New Developments/Regulatory Aspects
Patent Review
Patents by Year
Patents by Type
Patents by Company
Patents by Country
Patents by Assignee
Products and Developments
Mergers and Acquisitions
Awards for Drug Discovery Technologies
Regulatory Aspects
Chapter 11 Analysis of Market Opportunities
Factors Affecting the Drug Discovery Technologies Market
Drivers of the Drug Discovery Technologies Market
Current Challenges for the Drug Discovery Technologies Market
Chapter 12 Company Profiles
Agilent Technologies Inc.
Ametek Inc.
Arrayit Corp.
Beckton, Dickinson and Co. (BD Biosciences)
Biomax Informatics AG
Bio-Rad Laboratories
Bruker Corp.
Charles River Laboratories International, Inc.
Codex Biosolutions Inc.
Danaher Corp.
General Electric Co.
Hitachi High-Technologies Corp.
Illumina, Inc.
Integrated DNA Technologies, Inc.
Jeol USA, Inc.
Leco Corp.
Merck Kgaa (EMD Millipore)
Multispan Inc.
Perkinelmer Inc.
Promega Corp.
Qiagen N.V.
Roche Holding Ltd.
Shimadzu Corp.
Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/8ckdhi
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900